Search

Baxter International Inc

Closed

SectorHealthcare

25.8 0.98

Overview

Share price change

24h

Current

Min

25.78

Max

26.03

Key metrics

By Trading Economics

Income

141M

126M

Sales

259M

3B

EPS

0.56

Dividend yield

0.77

Profit margin

4.257

Employees

37,500

EBITDA

177M

474M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+0.27% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.77%

2.18%

Next Earnings

29 paź 2026

Next Dividend date

1 paź 2026

Next Ex Dividend date

27 lis 2026

Market Stats

By TradingEconomics

Market Cap

1.4B

13B

Previous open

24.82

Previous close

25.8

News Sentiment

By Acuity

12%

88%

10 / 339 Ranking in Healthcare

Baxter International Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 wrz 2026, 20:07 UTC

Baxter International Inc shares are higher during Friday's session, reflecting broader market gains, though they remain below the 20-day moving average.

3 wrz 2026, 23:01 UTC

Baxter International Inc shares are lower in after-market trading, reflecting a broader trend and trading significantly below its 20-day moving average.

2 wrz 2026, 20:08 UTC

Baxter International Inc. shares are higher, supported by gains in the Health Care Equipment sub-sector. The broader market also closed higher since Tuesday.

1 wrz 2026, 20:01 UTC

News

Baxter International shares are lower as the company appoints John Rogers as CFO amid broader market concerns over rising oil prices and inflation.

31 sie 2026, 23:01 UTC

News

Baxter International appoints John Rogers as CFO and EVP, adjusts credit agreement, and increases debt tender offer. Shares are higher in after-market trading.

29 sie 2026, 00:01 UTC

Baxter International Inc shares are higher in after-market trading, reflecting a rise since Friday's close amid increased market expectations for an interest rate hike.

28 sie 2026, 23:46 UTC

Baxter International Inc shares are higher in after-market trading, supported by rising expectations for a rate hike next month and upward pressure on Treasury yields.

27 sie 2026, 20:07 UTC

Baxter International Inc shares are lower amid a broader market decline, remaining below their 20-day moving average with no specific news to explain the movement.

26 sie 2026, 19:36 UTC

Baxter International Inc shares are higher today, having reached a session high earlier. No specific news was identified to explain the price movement.

25 sie 2026, 23:31 UTC

Baxter International Inc shares are higher in after-market trading. No specific news was identified to explain this movement amid broader market sentiment shifts.

24 sie 2026, 19:56 UTC

News

Baxter International appoints John Rogers as CFO amid restructuring and a $600 million debt tender offer. Analysts raise 2026 EPS estimate to $2.02.

21 sie 2026, 23:06 UTC

Baxter International Inc shares are higher in after-market trading, reflecting broader market gains alongside major stocks like Tesla and UnitedHealth.

20 sie 2026, 23:01 UTC

Baxter International shares are lower in after-market trading amid broader market pressures following declines in major companies like Walmart and concerns over consumer spending.

18 sie 2026, 19:46 UTC

News

Baxter International increases tender offer to $600 million amid strong demand, with shares gaining despite an earlier pullback from a session high.

17 sie 2026, 20:06 UTC

News

Baxter International is lower today amid a report advising against the stock due to declining earnings and disappointing revenue performance over five years.

13 sie 2026, 19:46 UTC

News

Baxter International recalls Duo-Vent Solution Set lots due to air bubble risks. Shares are trading higher since Wednesday's close despite the recall announcement.

12 sie 2026, 23:46 UTC

Baxter International Inc shares are higher in after-market trading, supported by recent inflation data that may influence Federal Reserve interest rate decisions.

11 sie 2026, 23:06 UTC

Baxter International Inc. shares traded roughly flat in after-market hours, reflecting a minor decline from earlier highs amid strong gains over the past month.

10 sie 2026, 23:16 UTC

Baxter International Inc shares are lower in after-market trading. No specific news was identified to explain this movement amid rising U.S. Treasury yields.

7 sie 2026, 23:51 UTC

Baxter International Inc shares are lower in after-market hours, retracing from earlier gains amid broader market sentiment influenced by a declining unemployment rate.

6 sie 2026, 19:36 UTC

Baxter International Inc. shares are lower today, with no specific news identified to explain the movement. The stock remains near its one-month range.

5 sie 2026, 20:01 UTC

Baxter International Inc shares are lower today, continuing a downward trend. The stock remains above its 20-day moving average despite recent declines.

4 sie 2026, 22:51 UTC

News

Baxter International shares are lower in after-market hours following the announcement of Interim CFO Anita Zielinski's resignation, effective September 15, 2026.

3 sie 2026, 23:02 UTC

Baxter International Inc shares are trading lower in after-market hours. Broader market volatility contributed to this decline without any specific company news.

31 lip 2026, 23:46 UTC

Baxter International shares are lower in after-market trading, following a brief session rise. Rising U.S. Treasury yields and crude oil prices heighten inflation concerns.

30 lip 2026, 23:21 UTC

Baxter International Inc shares are lower in after-market trading, reflecting unusual volatility despite strong performance over the past month.

29 lip 2026, 22:02 UTC

Baxter International Inc. shares are lower in after-market trading, mirroring the broader market's decline amid geopolitical tensions and inflation concerns.

28 lip 2026, 22:41 UTC

Baxter International Inc shares rose in after-market trading, continuing a trend of higher daily closes and remaining above the 20-day moving average.

27 lip 2026, 19:21 UTC

News

Baxter International shares are higher as TD Cowen raises the price target to $24.00, reflecting positive sentiment in the Health Care Equipment sector.

24 lip 2026, 19:02 UTC

Baxter International Inc shares are higher, reflecting market response to a decline in crude oil prices that eased inflationary pressures.

Peer Comparison

Price change

Baxter International Inc Forecast

Price Target

By TipRanks

0.27% upside

12 Months Forecast

Average 25.9 USD  0.27%

High 29 USD

Low 21 USD

Based on 10 Wall Street analysts offering 12 month price targets forBaxter International Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

10 ratings

1

Buy

9

Hold

0

Sell

Sentiment

By Acuity

10 / 339 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
help-icon Live chat